SCHEMBL435430

SCHEMBL435430

CCC(N)(CC)CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4618187 0.94
Ammonia Solution, Strong SCHEMBL22686496 0.91
SCHEMBL24509154 0.86
SCHEMBL11429186 0.84 FDPS (0.30)
SCHEMBL24897673 0.84 AAK1 (0.30)
SCHEMBL29391957 0.84 MEN1 (0.43)
SCHEMBL20712802 0.80 TSHR (0.30)
SCHEMBL27491942 0.79 FDPS (0.36)
SCHEMBL31531152 0.78
SCHEMBL4640156 0.77 FDPS (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578541-B1 COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-05-28 EP disclosed
EP-3215172-B1 MODIFICATIONS AND USES OF CONOTOXIN PEPTIDES KINETA CHRONIC PAIN LLC (US) 2023-04-26 EP disclosed
US-11618772-B2 Modifications and uses of conotoxin peptides KINETA CHRONIC PAIN, LLC 2023-04-04 US disclosed
US-11014970-B2 Modifications and uses of conotoxin peptides KINETA CHRONIC PAIN, LLC (US) 2021-05-25 US disclosed
US-20210122792-A1 MODIFICATIONS AND USES OF CONOTOXIN PEPTIDES KINETA CHRONIC PAIN, LLC (US) 2021-04-29 US disclosed
US-10947274-B1 Synthetic analgesic peptides of RgIA analogs UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2021-03-16 US disclosed
EP-3003344-B1 CONOTOXIN PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF UNIV UTAH RES FOUND (US) 2020-11-25 EP disclosed
US-10633417-B2 Conotoxin peptides, pharmaceutical compositions and uses thereof UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2020-04-28 US disclosed
EP-3578541-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITION, AND PROCESSES, RELATED THERETO Dow AgroSciences LLC (US) 2019-12-11 EP disclosed
US-10399933-B2 Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer BRISTOL-MYERS SQUIBB COMPANY (US) 2019-09-03 US disclosed
WO-2000043409-A2 ALPHA-CONOTOXIN PEPTIDES UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2000-07-27 WO disclosed
EP-0964691-A1 USE OF CONANTOKINS Cognetix, Inc. (US) 1999-12-22 EP disclosed
EP-0956292-A1 CONANTOKINS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1999-11-17 EP disclosed
US-5871572-A COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID SEIKO EPSON CORPORATION (JP) 1999-02-16 US disclosed
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
WO-1998003189-A1 USE OF CONANTOKINS COGNETIX, INC. (US) 1998-01-29 WO disclosed
WO-1998003541-A1 CONANTOKINS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1998-01-29 WO disclosed
EP-0757677-A1 BENZOCYCLOALKYLAZOLETHIONE DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1997-02-12 EP disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed
WO-1995029165-A2 BENZOCYCLOALKYLAZ0LETHIONE DERIVATIVES AS DOPAMIN BETA-HYDROXYLASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-11-02 WO disclosed